You need to enable JavaScript to run this app.
Industry calls for technical, scope changes in ICH S12 guideline
Regulatory News
Michael Mezher
Asia
Biologics/ biosimilars/ vaccines
Biotechnology
Europe
Global
North America
Preclinical study